Microgen plc
14 October 2003
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE
UNITED STATES, CANADA, AUSTRALIA OR JAPAN
FOR IMMEDIATE RELEASE
POSTING OF DOCUMENTS
Further to the announcement dated 10 October 2003 regarding the recommended
offer to be made by Close Brothers Corporate Finance Limited on behalf of
Microgen plc ('Microgen') for M.M.T. Computing plc ('M.M.T.'), the board of
Microgen announces that documents, comprising a shareholder circular convening
an extraordinary general meeting of Microgen on 5 November 2003 to approve the
acquisition, and listing particulars containing financial information relating
to Microgen and M.M.T., have been posted to Microgen shareholders.
In addition, M.M.T. shareholders have been sent an offer document, containing
details of the offer, the accompanying form of acceptance and the listing
particulars containing financial information relating to Microgen and M.M.T..
The first closing date of the offer is 3 November 2003.
The circular and listing particulars will shortly be available for inspection
at the UKLA's Document Viewing Facility, which is situated at: Financial
Services Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS (tel.
no. 020 7676 1000) during normal business hours on any weekday (Saturdays,
Sundays and public holidays excepted) while the offer remains open for
acceptance. The circular and listing particulars, together with the offer
document, are also available for inspection at the offices of Clyde & Co,
situated at: 51 Eastcheap, London EC3M 1JP and also at the registered office of
Microgen: 11 Park Street, Windsor, Berkshire SL4 1LU, during normal business
hours on any weekday (Saturdays, Sundays and public holidays excepted) while
the offer remains open for acceptance.
Enquiries:
Microgen
Martyn Ratcliffe (Executive Chairman) 01753 847 122
Mike Phillips (Finance Director)
Close Brothers (financial advisor to Microgen) 020 7655 3100
Simon Willis
Financial Dynamics (financial PR advisor to Microgen) 020 7831 3113
Giles Sanderson
Close Brothers Corporate Finance Limited ('Close Brothers'), which is regulated
in the United Kingdom by the Financial Services Authority, is acting
exclusively for Microgen and no one else in connection with the offer for
M.M.T. and will not be responsible to any person other than Microgen for
providing the protections afforded to clients of Close Brothers or for
providing advice in relation to the offer for M.M.T., the contents of this
announcement or any matters referred to herein.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.